Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Study holds implications for gene therapy and stem cell biology

Study holds implications for gene therapy and stem cell biology

Lower doses of chemo just as effective in childhood cancers

Lower doses of chemo just as effective in childhood cancers

More health benefits from green tea

More health benefits from green tea

Colon cancer patients who took aspirin regularly fared better after surgery

Colon cancer patients who took aspirin regularly fared better after surgery

Research findings help predict risk of blood clots in women receiving tamoxifen therapy for breast cancer

Research findings help predict risk of blood clots in women receiving tamoxifen therapy for breast cancer

New predictor for blood transplant success

New predictor for blood transplant success

Scientists inhibit tumor formation

Scientists inhibit tumor formation

New drug may help treat certain forms of leukemia

New drug may help treat certain forms of leukemia

Giving children access to drug clinical trials is crucial, clofarabine approval shows

Giving children access to drug clinical trials is crucial, clofarabine approval shows

New prognostic markers help identify risk of relapse

New prognostic markers help identify risk of relapse

Children treated for soft tissue sarcomas at greater risk of second cancers

Children treated for soft tissue sarcomas at greater risk of second cancers

Australian clinical trial of potent new anticancer drug (CYT997)

Australian clinical trial of potent new anticancer drug (CYT997)

National clinical trial examines new option for kidney cancer patients

National clinical trial examines new option for kidney cancer patients

Herceptin in combination with chemotherapy reduces risk of breast cancer recurrence in women with with early-stage breast cancer

Herceptin in combination with chemotherapy reduces risk of breast cancer recurrence in women with with early-stage breast cancer

P12 protein influences key cell-signaling pathway

P12 protein influences key cell-signaling pathway

High risk of second cancers in survivors of childhood soft tissue sarcomas

High risk of second cancers in survivors of childhood soft tissue sarcomas

Pattern of gene expression predicts multiple drug resistance, treatment failure in pediatric leukemia

Pattern of gene expression predicts multiple drug resistance, treatment failure in pediatric leukemia

Increasing benefit seen in novel drug AMN107, that treats Gleevec resistance

Increasing benefit seen in novel drug AMN107, that treats Gleevec resistance

Day care in infancy protects against childhood leukaemia

Day care in infancy protects against childhood leukaemia

Enzyme that helps trigger the development of leukemia

Enzyme that helps trigger the development of leukemia